Archived Releases

April 2, 2019
Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam
REHOVOT, Israel and BRIDGEWATER, N.J. , April 02, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in
Displaying 1 - 10 of 163